XML 116 R75.htm IDEA: XBRL DOCUMENT
v3.20.2

Stockholders' Deficiency and Members' Equity (Tables) (Brooklyn ImmunoTherapeutics, LLC) (10-K) | 12 Months Ended
--- | ---
Dec. 31, 2019
Schedule of Stock Option Activity | Stock Option Activity The following table summarizes stock option activities for the years ended December 31, 2019 and 2018:
|  | Outstanding Options |  |  | Weighted Average Exercise Price per Share |  |  | Weighted Average Remaining Contractual Life (in years) |  |  | Aggregate Intrinsic Value |
Outstanding January 1, 2018 |  |  | 156,000 |  |  | $ | 17.74 |  |  | $ | 7.12 |  |  | $ | - |
Granted |  |  | 2,000 |  |  |  | 4.44 |  |  |  | - |  |  |  | - |
Exercised |  |  | - |  |  |  | - |  |  |  | - |  |  |  | - |
Cancelled |  |  | (6,000 | ) |  |  | 10.42 |  |  |  | - |  |  |  | - |
Forfeited |  |  | (4,000 | ) |  |  | 6.38 |  |  |  | - |  |  |  | - |
Expired |  |  | (1,000 | ) |  |  | 16.00 |  |  |  | - |  |  |  | - |
Outstanding December 31, 2018 |  |  | 147,000 |  |  |  | 18.20 |  |  |  | 6.08 |  |  |  | - |
Granted |  |  | 3,000 |  |  |  | 3.15 |  |  |  | - |  |  |  | - |
Exercised |  |  | - |  |  |  | - |  |  |  | - |  |  |  | - |
Cancelled |  |  | (6,000 | ) |  |  | 13.32 |  |  |  | - |  |  |  | - |
Forfeited |  |  | (2,000 | ) |  |  | 6.24 |  |  |  | - |  |  |  | - |
Expired |  |  | - |  |  |  | - |  |  |  | - |  |  |  | - |
Outstanding December 31, 2019 |  |  | 142,000 |  |  | $ | 18.26 |  |  |  | 5.14 |  |  | $ | - |
Options vested and exercisable at December 31, 2019 |  |  | 140,000 |  |  | $ | 18.43 |  |  |  | 5.10 |  |  | $ | - |
Brooklyn Immunotherapeutics, LLC [Member] |
Schedule of Stock Option Activity | The following represents activity related to the Predecessor’s stock options during the period from the January 1, 2018 through November 5, 2018:
|  | Number of Options |  |  | Weighted Average Exercise Price |  |  | Weighted Average Remaining Life in Years |  |  | Aggregate Intrinsic Value |
Outstanding, January 1, 2018 |  |  | 1,165 |  |  | $ | 208 |  |  |  | 1.5 |  |  | $ | - |
Granted |  |  | - |  |  |  | - |  |  |  | - |  |  |  | - |
Exercised |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Forfeited |  |  | (80 | ) |  | $ | 300 |  |  |  | - |  |  |  | - |
Outstanding, November 5, 2018 |  |  | 1,085 |  |  | $ | 201 |  |  |  | 0.7 |  |  | $ | - |
Exercisable, November 5, 2018 |  |  | 1,085 |  |  | $ | 201 |  |  |  | 0.7 |  |  | $ | - |
Schedule of Stock Options Outstanding and Exercisable | The following table presents information related to stock options at November 5, 2018:
Options Outstanding |  |  | Options Exercisable |
Exercise Price |  |  | Outstanding Number of Options |  |  | Weighted Average Remaining Life In Years |  |  | Exercisable Number of Options |
$ | 200 |  |  |  | 1,075 |  |  |  | 0.7 |  |  |  | 1,075 |
$ | 300 |  |  |  | 10 |  |  |  | 0.2 |  |  |  | 10 |
|  |  |  |  | 1,085 |  |  |  | 0.7 |  |  |  | 1,085 |

X
- Definition Schedule of stock options outstanding and exercisable [Table Text Block]. + References No definition available. + Details
Name: | NTN_ScheduleOfStockOptionsOutstandingAndExercisable
Namespace Prefix: | NTN_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (d) -URI http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (e) -URI http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (c)(1) -URI http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901 + Details
Name: | us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Details
Name: | srt_ConsolidatedEntitiesAxis=NTN_BrooklynImmunotherpeuticsLLCMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |